life science investing Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline
SAGA Metals Mobilizes Final Team for Major Drill Program at Radar Project in Labrador, Targeting Maiden Mineral Resource Estimate & Provides Corporate Update